checkAd

     141  0 Kommentare Perk Labs Announces Proposed Non-Brokered Private Placement and Announces Resignation of CLO and Director

    VANCOUVER, BC / ACCESSWIRE / July 14, 2023 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ("Perk" or the "Company") the company that specializes in ordering and payment technology, today announced that it is proposing a non-brokered private …

    VANCOUVER, BC / ACCESSWIRE / July 14, 2023 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ("Perk" or the "Company") the company that specializes in ordering and payment technology, today announced that it is proposing a non-brokered private placement of units and convertible debentures. Additionally, the Company announced the resignation of Jonathan Hoyles, Chief Legal Officer and Director, who will be leaving Perk Labs to pursue another opportunity.

    Private Placement of Units

    The Company is proposing a non-brokered private placement of up to 6,250,000 units ("Units") at a price of $0.016 per Unit for gross proceeds of up to $100,000. Each Unit will consist of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to purchase one additional Common Share at a price of $0.05 per Common Share for a period of 24 months from the Closing (as defined below).

    Private Placement of Convertible Debentures

    Perk Labs also announced today that it is proposing a non-brokered private placement of convertible debentures for gross proceeds of up to $250,000. The convertible debentures will be offered on varying terms, including interest rates ranging from 5% to 15% and differing acceleration terms and maturity dates specific to the terms of each convertible debenture agreement.

    The convertible debentures will be convertible into common shares of Perk Labs at a conversion price of $0.05 per share, subject to the terms and conditions set forth in the specific convertible debenture agreement.

    The private placement of the Units and the convertible debentures is expected to close on or before August 24, 2023 (the "Closing"). The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placement will be subject to a statutory hold period of four months and one day following the Closing. The Company intends to use the net proceeds from the private placements for general working capital purposes, accounts payable, and employee salaries.

    Resignation of Jonathan Hoyles

    Perk Labs also announced the resignation of Jonathan Hoyles, Chief Legal Officer and Director, effective July 13, 2023. Jonathan has decided to pursue another opportunity, and his departure from Perk Labs is amicable. The Company would like to express its gratitude for Jonathan's valuable contributions during his tenure and wishes him success in his future endeavors. The Company is currently in the process of evaluating potential candidates to fill the vacancies on the board of directors.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Perk Labs Announces Proposed Non-Brokered Private Placement and Announces Resignation of CLO and Director VANCOUVER, BC / ACCESSWIRE / July 14, 2023 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ("Perk" or the "Company") the company that specializes in ordering and payment technology, today announced that it is proposing a non-brokered private …